NEW DELHI : Bharat Biotech International’s covid-19 vaccine Covaxin can protect against the new strain of novel coronavirus discovered in the UK, a pre-print of an in-vitro study conducted by the company showed.The company had conducted a plaque reduction neutralization test (PRNT50) study, wherein it collected blood sera from the 26 individuals who had received Covaxin, and tested them against the new UK strain as well as another strain of the virus that the company had tested before.Also Read | How India has become an unequal republicSera from vaccinated individuals showed comparable neutralisation antibody activity against both strains, which indicated that the vaccine worked against the new strain.“It was reassuring from the PRNT50 data.